AI assistant
Sending…
Amphastar Pharmaceuticals, Inc. — Director's Dealing 2017
Nov 18, 2017
10216_dirs_2017-11-17_326f3120-98b0-492c-9666-6e7a8bed19d6.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Amphastar Pharmaceuticals, Inc. (AMPH)
CIK: 0001297184
Period of Report: 2017-11-15
Reporting Person: Gerst Diane G. (EVP, QA & Regulatory Affairs)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-11-15 | Common Stock | S | 523 | $17.7659 | Disposed | 32256 | Direct |
Footnotes
F1: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 5, 2017.
More from Amphastar Pharmaceuticals, Inc.
Investor Presentation
2026
May 14
Interim / Quarterly Report
2026
May 7
Investor Presentation
2026
May 7
Investor Presentation
2026
Apr 14
Annual Report
2026
Apr 13
Proxy Solicitation & Information Statement
2026
Apr 13
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 17
Director's Dealing
2026
Mar 17
Director's Dealing
2026
Mar 17